Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-76

First 76 Last

Share
Profile

Follow
turbo

717 Posts.

585

02/04/25

11:15

Post #: 78513281
Share

Originally posted by Sirocco1971: ↑

Thankfully NEU isn't considered a gene therapy company.
Small Molecule Drugs: These are chemical compounds that interact with biological pathways to modify disease processes. They typically bind to proteins, enzymes, or receptors to regulate cellular activity. Small molecule drugs are often taken as pills or injections and are widely used in conditions like neurological disorders, cancer, and infections.
A key difference is that gene therapy aims to fix the root cause at the genetic level, while small molecule drugs work by controlling symptoms or disease progression without altering genes.
It has clearly impacted sentiment in the sector though, compounded locally off the back on Opthea's demise.

Expand

To try and put a silver lining on it, some of NEU's potential competitors are gene therapy assets.

NEU Price at posting: $11.02 Sentiment: Buy Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

PH2

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

DYL

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

First 76 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $12.75		Change -0.210(1.62%)		Mkt cap ! $1.609B

Open	High	Low	Value	Volume
$12.82	$13.05	$12.70	$3.071M	238.1K

Buyers (Bids)

No.	Vol.	Price($)
1	76	$12.75

Sellers (Offers)

Price($)	Vol.	No.
$12.76	469	9

View Market Depth

No.	Vol.	Price($)
9	577	12.790
4	691	12.780
4	629	12.770
8	1639	12.760
8	1865	12.750

Price($)	Vol.	No.
12.810	945	12
12.820	1140	12
12.830	1861	10
12.840	1587	8
12.850	1417	6

Last trade - 14.34pm 17/06/2025 (20 minute delay)

NEU (ASX) Chart

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-76

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-76

Top Stories

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News